(Q44407315)

2 December 2017

title

Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome (English)

1 reference

10.1007/S00467-003-1095-3

2 December 2017

1 reference

https://api.crossref.org/works/10.1007/S00467-003-1095-3

25 December 2023

author name string

Anurag Bajpai

1

1 reference

2 December 2017

Arvind Bagga

2

1 reference

2 December 2017

Pankaj Hari

3

1 reference

2 December 2017

Amit Dinda

4

1 reference

2 December 2017

Rajendra N. Srivastava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700961

25 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12700961

25 December 2023

publication date

21 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

18

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

351-356

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-003-1095-3

2 December 2017

exact match

0 references

cites work

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

1 reference

12 December 2020

Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome

1 reference

12 December 2020

Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

1 reference

12 December 2020

Intensive pulse therapies for focal glomerulosclerosis in South African children

1 reference

12 December 2020

Cyclosporine in the therapy of steroid-resistant idiopathic nephrotic syndrome.

1 reference

12 December 2020

Consensus statement on management of steroid sensitive nephrotic syndrome.

1 reference

12 December 2020

Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease

1 reference

12 December 2020

Nephrotic syndrome in indian children

1 reference

12 December 2020

Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis

1 reference

12 December 2020

Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.

1 reference

12 December 2020

Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.

1 reference

12 December 2020

Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide

1 reference

12 December 2020

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review

1 reference

12 December 2020

Update on cyclophosphamide for systemic lupus erythematosus

1 reference

12 December 2020

Side-effects of intravenous cyclophosphamide pulse therapy

1 reference

12 December 2020

10.1007/S00467-003-1095-3

Identifiers

DOI

0 references

1 reference